Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Farmaceutica RemediaBSE:RMAH +0.23%58 Dividend Yield % is 4.60% as of Jul. 18, 2026, which is 26% below its 10-year median of 6.19. GuruFocus rates BSE:RMAH with a GF Score™ of 58/100 and a GF Value™ of lei0.79 (Fairly Valued). The stock has 8 warning signs investors should review. Among 69 Medical Distribution companies, Farmaceutica Remedia ranks better than 73.91% on this metric.
As of today (2026-07-18), the Trailing Annual Dividend Yield of Farmaceutica Remedia is 4.60%.
Warning Sign:
Farmaceutica Remedia SA stock Dividend Yield % is close to 5-year low.
The historical rank and industry rank for Farmaceutica Remedia's Dividend Yield % or its related term are showing as below:
BSE:RMAH'
s Dividend Yield % Range Over the Past 10 Years
Min: 1.43 Med: 6.19 Max: 25
Current: 4.6
During the past 13 years, the highest Dividend Yield of Farmaceutica Remedia was 25.00%. The lowest was 1.43%. And the median was 6.19%.
BSE:RMAH's Dividend Yield % is ranked better than 73.91% of 69
companies
in the Medical Distribution industry
Industry Median: 2.78
vs BSE:RMAH: 4.60
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Farmaceutica Remedia SA is 0.77, which seems too high.
During the past 13 years, the highest Dividend Payout Ratio of Farmaceutica Remedia was 2.06. The lowest was 0.24. And the median was 0.65.
During the past 12 months, Farmaceutica Remedia's average Dividends Per Share Growth Rate was -20.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -7.20% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 0.50% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Farmaceutica Remedia was 146.60% per year. The lowest was -30.70% per year. And the median was -7.20% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Farmaceutica Remedia Dividend Yield % Related Terms
Farmaceutica Remedia Dividend Yield % Historical Data
* Premium members only.
The historical data trend for Farmaceutica Remedia's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSE:RMAH vs MCK, CAH, COR: Dividend Yield % Comparison
For the Medical Distribution subindustry, Farmaceutica Remedia's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Farmaceutica Remedia Dividend Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Farmaceutica Remedia's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Farmaceutica Remedia's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Farmaceutica Remedia Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
RON 0.040000
2025-09-11
2025-09-12
2025-09-30
Cash Dividend
annually
RON:RON 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Farmaceutica Remedia's Trailing Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Farmaceutica Remedia (BSE:RMAH) has a Dividend Yield % of 4.60% as of Jul. 18, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Farmaceutica Remedia and its competitors. This is 26% below median its historical median of 6.19. Over the past decade, Farmaceutica Remedia's Dividend Yield % has ranged from 1.43 to 25.00. According to the industry distribution chart, Farmaceutica Remedia ranks #18 out of 69 companies in the Medical Distribution industry, placing it in the top 26.1%.
Is Farmaceutica Remedia's Dividend Yield % too high?
Farmaceutica Remedia's current Dividend Yield % of 4.60% is 26% below median its 10-year median of 6.19. Over the past 10 years, this metric has ranged from a low of 1.43 to a high of 25.00. The Medical Distribution industry median Dividend Yield % is 2.78. Farmaceutica Remedia's value of 4.60% is 65.5% above this industry median. Based on the distribution chart, Farmaceutica Remedia ranks #18 out of 69 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Farmaceutica Remedia has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Farmaceutica Remedia's Dividend Yield % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Farmaceutica Remedia ranks #18 out of 69 companies for Dividend Yield %. This puts Farmaceutica Remedia in the upper half of its industry. The industry median Dividend Yield % is 2.78. Farmaceutica Remedia's value of 4.60% is 65.5% above this benchmark. Historically, Farmaceutica Remedia's own Dividend Yield % has ranged from 1.43 to 25.00 over the past decade. While the company's 10-year median is 6.19 vs. the industry median of 2.78, Farmaceutica Remedia has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Distribution company?
The median Dividend Yield % among Medical Distribution companies is 2.78, based on 69 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Farmaceutica Remedia's current Dividend Yield % of 4.60% is 65.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Farmaceutica Remedia and its competitors. For the Medical Distribution industry, the median Dividend Yield % is 2.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Farmaceutica Remedia's current Dividend Yield % is 4.60%, which is 26% below median its own 10-year median of 6.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farmaceutica Remedia stock overvalued right now?
Based on GuruFocus' analysis, Farmaceutica Remedia (BSE:RMAH) is currently considered Fairly Valued. The stock's GF Value™ is lei0.79, compared to a current price of lei0.87 — trading 10.1% above its estimated fair value. The current Dividend Yield % is 4.60%, which is 26% below median its 10-year median of 6.19 and 65.5% above the Medical Distribution industry median of 2.78. Farmaceutica Remedia's overall GF Score™ is 58/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Farmaceutica Remedia (BSE:RMAH), the current Dividend Yield % is 4.60% as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Farmaceutica Remedia (BSE:RMAH) Overvalued in 2026?
Based on GuruFocus' analysis, Farmaceutica Remedia stock appears to be overvalued.
The current stock price of lei0.87 is trading 10.1% above its estimated GF Value™ of lei0.79.
GuruFocus considers Farmaceutica Remedia to be Fairly Valued.
Key valuation signals for BSE:RMAH:
Dividend Yield %: 4.60% (26% below median its 10-year median of 6.19)
GF Value™: lei0.79 vs. price of lei0.87 (10.1% above fair value)
Industry Position: 65.5% above the Medical Distribution median (#18 of 69)
No single metric tells the full story. See the BSE:RMAH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Farmaceutica Remedia SA is engaged in drug sales activities, marketing, and health products. It provides marketing and promotion services for medicines. The company offers services offered, including logistics services, medical marketing, and promotion, and pharmaceutical registrations, but also professionalism and performance differentiate the company from other competitors and position it as a partner for launching, promoting, and distributing pharmaceutical products in Romania and other countries in Eastern Europe.
58GF Score
Get the complete analysis for BSE:RMAH
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSE:RMAH has been successfully added to your 
